Cancer Clinical Trial
Official title:
Personalized Patient Alerts and Care Pathways to Prompt Prevention Interventions for Combined Alcohol and Tobacco Users in Primary Care
Tobacco and alcohol use present multiplicative risk for aerodigestive cancers. Reducing
alcohol consumption improves smoking cessation outcomes and reduces cancer risk. Risky
alcohol consumption and smoking are often treated separately despite concurrent treatment
potentially leading to better outcomes for each. However, no rapidly scalable program exists
for combined interventions in primary care clinics spread across wide geographic areas. This
cluster randomized trial aims to report on the effects of a novel clinical decision support
system (CDSS) on intervention rates by primary care practitioners addressing risky alcohol
use in a smoking cessation program.
The investigators will be implementing a clinical decision support system (CDSS) in 221
primary care sites participating in the Smoking Treatment for Ontario Patients (STOP) program
across Ontario, Canada. Sites will be blindly allocated to one of two clinical decision
support systems guiding practitioners to provide a risky alcohol use intervention to smokers
attempting to quit using nicotine replacement therapy (NRT). Risky alcohol use is defined as
drinking above the Canadian Cancer Society's low-risk drinking guidelines. Primary analysis
will measure the proportion of risky drinkers offered an alcohol intervention in each CDSS
arm at baseline. Patients will be contacted by phone or email to track smoking cessation and
alcohol consumption rates at 6- and 12-month follow up.
Upon completion of the trial, the effect of different clinical decision support systems on
practitioner behavior, and on client tobacco and alcohol use, will be discussed. If the CDSS
successfully promotes SBIRT for risky alcohol use in a primary care setting and/or improves
patient-level outcomes, including smoking cessation rates and alcohol use reduction, this
tool can be used as a model for other web-based behavior change interventions integrated into
primary care practice.
Background: Primary care providers work in busy settings responding to a variety of acute and
chronic problems. Implementing even brief evidence-based interventions for cancer risk
behaviors, such as tobacco smoking and excess alcohol consumption, is sub-optimal due to time
and knowledge constraints. These behaviors cluster in the same person and confer a
multiplicative, positively associated risk for aero-digestive cancers but are often addressed
separately, if at all, despite alcohol consumption undermining smoking cessation. Processes
that reduce time and effort and yet increase practitioner effectiveness show promise to
increase adoption of such practices. Computerized clinical decision support systems (CDSS)
within practices allow for prompt procedural knowledge for practitioners, simplifies the
decision-making process, and provides recommendations for patient care.
The initiation of the STOP Program (Smoking Treatment for Ontario Patients - an Ontario-wide
initiative providing smoking cessation to eligible smokers who wish to quit), has
demonstrated that such a system allows for rapid adoption of smoking cessation interventions
in primary care with 189 sites (80% of eligible sites) in Ontario treating 40,000 smokers in
2 years. Approximately 36% consume alcohol above Canadian Cancer Society (CCS) guidelines
(less than one drink per day for women; less then two drinks per day for men; no engagement
in binge drinking) and those that do have a lower quit rate.
A combined alcohol and tobacco intervention delivered systematically using such a platform
has never been studied before, which constitutes a missed opportunity to simultaneously
address two closely related risk factors for cancer. Thus, implementation of a CDSS within
the daily clinical workflow is a novel concept for cancer prevention with high potential to
address the lack of brief interventions by health care providers.
Objective: Assess the effectiveness of a CDSS to increase the rates of brief alcohol
intervention by healthcare providers and to reduce alcohol consumption in adult smokers
making a quit attempt.
Methodology: Organizations from the STOP Program will be randomly allocated (1:1) to Group A
or Group B.
Patient Population: Adult consenting smokers of the STOP Program identified as drinking above
the sex-specific cut off at baseline will be eligible for the intervention.
Intervention: Half the sites will have a computer prompt built into STOP's data collection
system, which will appear for any participant identified as drinking above the sex-specific
cut off at baseline (Group A). The reminder will provide the practitioners with a five minute
script advising their patient to reduce alcohol consumption to increase their chances of
quitting smoking, and will be prompted to provide a self-help booklet to reduce alcohol
intake. Sites without the prompt (Group B) will not receive reminders but will have access to
the same resources.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|